Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Atlantic Healthcare Names US Management

Executive Summary

Atlantic Healthcare plc. has named the management team which will lead its newly established US commercial and business development operations, based in North Carolina. The specialty pharma company, which focuses on gastrointestinal disorders, has appointed Sireesh Appajosyula vice president (VP) product commercialisation, Jonathan Drutz VP corporate and business development and Jordan Zwick director of corporate and business development. Appajosyula joins Atlantic from Salix Pharmaceuticals, where he led the company’s inflammatory bowel disease division. Drutz has been involved in a variety of life science ventures, acting as a business development executive, investor and consultant. Zwick most recently led business development and corporate strategy at Chimerix, having previously been at Salix and Medtronic.

You may also be interested in...

Executives On The Move: PYC Therapeutics Gets Chief Development Officer, New Chief Commercial Officer At Everest Medicines

New Directors Join Ambrx, Synedgen and Cogent Biosciences.

Coronavirus Update: Moderna’s Variant-Targeting Vaccine Moves Into Trial, J&J Looks Set For US Authorization

A round up of COVID-19 developments, also including news on the EMA beginning a rolling review of Celltrion's antibody therapy, and progress for Novavax and Moderna in Japan.

Coronavirus Update: Pfizer Pledges To Double US Vaccine Output

A round-up of the latest developments, including Celltrion’s new antibody cocktail and SK Biosience and Novavax expanding their collaboration.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts